Sound Exposure Promotes Intratympanic Drug Delivery to the Inner Ear

被引:1
|
作者
Ungar, Omer J. [1 ,2 ]
Situ, Yumai [2 ]
Spiegel, Jennifer L. [1 ,2 ,3 ]
Chen, Joseph M. [1 ,2 ]
Lin, Vincent Y. W. [1 ,2 ]
Le, Trung N. [1 ,2 ]
机构
[1] Univ Toronto, Fac Med, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Hurvitz Brain Sci Program, Biol Sci Platform, Toronto, ON, Canada
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Otorhinolaryngol, Munich, Germany
关键词
dexamethasone; gentamicin; inner ear pharmacodynamics; intratympanic injection; local drug delivery; Meni & egrave; re disease; steroid; sudden hearing loss; HEARING-LOSS; INTRAVENOUS DELIVERY; DEXAMETHASONE; METHYLPREDNISOLONE;
D O I
10.1002/ohn.801
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
ObjectiveTo investigate the impact of sound exposure, with the resultant windows vibration on perilymphatic concentrations following intratympanic (IT) dexamethasone and gentamicin in an animal model.Study DesignAnimal model blinded study.SettingAnimal facility of a tertiary medical center.MethodsBilateral IT dexamethasone or gentamicin was applied to 15 tested rats. Following injections, each rat was exposed for 3 minutes to free field 30 dB sound pressure level (SPL), 512 vHz noise, with 1 external auditory canal plugged (contralateral control). Following noise exposure, perilymph was obtained from both ears. Drug concentrations were measured using ultrahigh-performance liquid chromatography-mass spectrometer.ResultsFor dexamethasone, the average (+/- SD) perilymphatic steroidal concentration was 0.417 mu g/mL (+/- 0.549) in the control ears versus 0.487 mu g/mL (+/- 0.636) in the sound-exposed ears (P = .008). The average (+/- SD) gentamicin perilymphatic concentration was 8.628 mu g/mL (+/- 2.549) in the sound-exposed ears, compared to 4.930 mu g/mL (+/- 0.668) in the contralateral control (nonsound exposed) ears. Sound exposure promoted steroidal and gentamicin diffusion to the inner ear by an averaged (+/- SD) factor of 1.431 and 1.730 (+/- 0.291 and 0.339), respectively.ConclusionLow-intensity noise (30 dB SPL) was found to enhance dexamethasone phosphate and gentamicin diffusion to the inner ear (by an averaged factor of similar to 1.4 and 1.7, respectively) in a murine model.
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 50 条
  • [1] Intratympanic drug delivery for the treatment of inner ear diseases
    Herraiz, Carlos
    Miguel Aparicio, Jose
    Plaza, Guillermo
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2010, 61 (03): : 225 - 232
  • [2] Intratympanic drug delivery systems to treat inner ear impairments
    Thu Nhan Nguyen
    Park, Jeong-Sook
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (01) : 93 - 118
  • [3] Intratympanic drug delivery systems to treat inner ear impairments
    Thu Nhan Nguyen
    Jeong-Sook Park
    Journal of Pharmaceutical Investigation, 2023, 53 : 93 - 118
  • [4] Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear
    Yoon, Ji Young
    Yang, Keum-Jin
    Kim, Da Eun
    Lee, Kyu-Yup
    Park, Shi-Nae
    Kim, Dong-Kee
    Kim, Jong-Duk
    BIOMATERIALS, 2015, 73 : 243 - 253
  • [5] Drug delivery to the inner ear
    Wise, Andrew K.
    Gillespie, Lisa N.
    JOURNAL OF NEURAL ENGINEERING, 2012, 9 (06)
  • [6] Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications
    Salt, Alec N.
    Plontke, Stefan K.
    HEARING RESEARCH, 2018, 368 : 28 - 40
  • [7] Microtechnologies for inner ear drug delivery
    Forouzandeh, Farzad
    Borkholder, David A.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2020, 28 (05): : 323 - 328
  • [8] Drug and gene delivery into inner ear
    Kanzaki, Sho
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 42P - 42P
  • [9] Novel self-degradable prodrug blend thermogel for intratympanic drug delivery to treat inner ear diseases
    Le, Thi Phuc
    Yu, Yang
    Kwon, Hyuk Chan
    Shin, Sun-Ae
    Park, Yong-Ho
    Huh, Kang Moo
    CHEMICAL ENGINEERING JOURNAL, 2023, 476
  • [10] Ear Cubes for local controlled drug delivery to the inner ear
    Gehrke, M.
    Sircoglou, J.
    Gnansia, D.
    Tourrel, G.
    Willart, J. -F.
    Danede, F.
    Lacante, E.
    Vincent, C.
    Siepmann, F.
    Siepmann, J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 509 (1-2) : 85 - 94